Other Guidelines | Page 2 | European Cystic Fibrosis Society (ECFS)

Treating cystic fibrosis before birth: What we learned from an unsuccessful case

Lower inflammation is related to greater energy levels in adults with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor

CFTR modulators and pregnancy outcomes: early findings from a nationwide cohort study

AI-Powered Home Monitoring for Cystic Fibrosis Flare-Ups in Kids and Adults

Mental health is related to adherence through self-efficacy and perceived barriers

Reassurance in Pregnancy and Cystic Fibrosis

Do people with cystic fibrosis experience side effects from Elexacaftor/Tezacaftor/Ivacaftor because of high drug levels?

How people with CF access CFTR modulators in countries where coverage is not provided by health systems

Response to CFTR modulators of the rare CFTR variants L383S, I507del, L1065P and R1066H

Tracking the effects of ETI treatment on pancreas in an infant over 1.7 years using stool tests

first
previous
1
2
3
4
5
6
7
8
9
…
next
last